Advertisement
New Zealand markets closed
  • NZX 50

    11,864.89
    -7.75 (-0.07%)
     
  • NZD/USD

    0.6144
    -0.0027 (-0.43%)
     
  • NZD/EUR

    0.5733
    -0.0008 (-0.14%)
     
  • ALL ORDS

    7,974.80
    -27.70 (-0.35%)
     
  • ASX 200

    7,724.30
    -25.40 (-0.33%)
     
  • OIL

    78.49
    -0.13 (-0.17%)
     
  • GOLD

    2,348.40
    +30.40 (+1.31%)
     
  • NASDAQ

    19,659.80
    +82.88 (+0.42%)
     
  • FTSE

    8,146.86
    -16.81 (-0.21%)
     
  • Dow Jones

    38,589.16
    -57.94 (-0.15%)
     
  • DAX

    18,002.02
    -263.66 (-1.44%)
     
  • Hang Seng

    17,941.78
    -170.85 (-0.94%)
     
  • NIKKEI 225

    38,814.56
    +94.09 (+0.24%)
     
  • NZD/JPY

    96.6520
    -0.1680 (-0.17%)
     

Applied Materials (AMAT) Q2 Earnings & Revenues Top Estimates

Applied Materials Inc. AMAT reported second-quarter fiscal 2024 non-GAAP earnings of $2.09 per share, surpassing the Zacks Consensus Estimate by 6.1%. Moreover, the figure improved 5% from the year-ago quarter’s reported number.

Net revenues of $6.65 billion were up 0.2% from the year-ago quarter. The figure surpassed the Zacks Consensus Estimate of $6.51 billion.

Strong momentum in the Applied Global Services (“AGS”) segment was a positive. Improving the Display segment contributed well. AMAT also experienced solid momentum across China and Southeast Asia in the reported quarter.

Shares of Applied Materials have gained 32.2% over a year, outperforming the industry’s rally of 26.3%.

However, softness in the Semiconductor Systems segment remained a headwind. Weakening momentum across Taiwan, Korea, the United States and Europe was a major negative.

Applied Materials, Inc. Price, Consensus and EPS Surprise

 

Applied Materials, Inc. Price, Consensus and EPS Surprise
Applied Materials, Inc. Price, Consensus and EPS Surprise

Applied Materials, Inc. price-consensus-eps-surprise-chart | Applied Materials, Inc. Quote

Segments in Detail

Semiconductor Systems generated revenues worth $4.9 billion, which contributed 73.7% to its net revenues, reflecting a decline of 1.5% from the year-ago quarter. The figure surpassed the Zacks Consensus Estimate of $4.8 billion.

AGS reported revenues of $1.53 billion (23% of net revenues), up 7.1% from the prior-year quarter. The figure surpassed the Zacks Consensus Estimate of $1.50 billion.

Revenues from Display and Adjacent Markets were $179 million (2.8% of net revenues), up 6.5% from the year-ago quarter. The figure beat the Zacks Consensus Estimate of $150 million.

Corporate and Other revenues were $36 million (0.5% of revenues), down 36.8% year over year.

Revenues by Geography

The United States, Europe, Japan, Korea, Taiwan, Southeast Asia and China generated revenues of $853 million, $289 million, $453 million, $988 million, $1.02 billion, $213 million and $2.83 billion, contributing 13%, 4%, 7%, 15%, 15%, 3% and 43% to net sales, respectively.

Revenues in Southeast Asia and China increased 35.7% and 101.5%, respectively, from the year-ago quarter. Revenues in the United States, Europe, Japan, Korea, Taiwan and Southeast Asia fell 23.4%, 39.4%, 1.5%, 37.6% and 28.9%, respectively, from the year-ago quarter.

Operating Results

The non-GAAP gross margin was 47.5%, which expanded 70 basis points (bps) from the year-ago quarter.

Operating expenses were $1.24 billion, up 4.9% from the year-ago quarter. As a percentage of sales, the figure expanded 90 bps from the year-earlier quarter to 18.7%.

The non-GAAP operating margin of 29% for the reported quarter contracted 10 bps year over year.

Balance Sheet & Cash Flow

As of Apr 28, 2024, cash, cash equivalent balances, and short-term investments were $7.6 billion, up from $7.5 billion as of Jan 28, 2024.

Inventories were $5.7 billion in second-quarter fiscal 2024 compared with $5.6 billion in first-quarter fiscal 2024. Accounts receivables increased to $4.8 billion in the reported quarter from $4.7 billion in the previous quarter.

The long-term debt was $5.463 billion at the end of the reported quarter compared with $5.462 billion at the end of the previous quarter.

Applied Materials generated a cash flow of $1.4 billion, down from $2.3 billion in the prior quarter.

AMAT returned $1.09 billion to its shareholders, of which share repurchases were worth $820 million and dividend payments amounted to $266 million.

Guidance

For third-quarter fiscal 2024, Applied Materials expects net sales of $6.65 billion (+/-$400 million). The Zacks Consensus Estimate for the same is pegged at $6.5 billion.

AMAT anticipates Semiconductor Systems, AGS and Display sales to be $4.80 billion, $1.57 billion and $245 million, respectively.

Applied Materials expects a non-GAAP gross margin of 47% and non-GAAP operating expenses of $1.26 billion. It projects a non-GAAP tax rate of 12.3%.

Management expects non-GAAP earnings per share of $1.83-$2.19. The Zacks Consensus Estimate for the same is pegged at $1.94.

Zacks Rank & Stocks to Consider

Currently, Applied Materials carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader technology sector are Salesforce CRM, CrowdStrike CRWD and Intuit INTU, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Shares of Salesforce have gained 8.3% in the year-to-date period. The long-term earnings growth rate for CRM is 17.45%.

Shares of CrowdStrike have gained 32.8% in the year-to-date period. The long-term earnings growth rate for CRWD is projected at 22.31%.

Shares of Intuit have gained 4.8% in the year-to-date period. The long-term earnings growth rate for INTU is 14.57%.

ADVERTISEMENT

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Salesforce Inc. (CRM) : Free Stock Analysis Report

Intuit Inc. (INTU) : Free Stock Analysis Report

Applied Materials, Inc. (AMAT) : Free Stock Analysis Report

CrowdStrike (CRWD) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research